An open-label, randomized phase II study of adecatumumab, a fully human anti-EpCAM antibody, as monotherapy in patients with metastatic breast cancer

Marcus Schmidt, M. E. Scheulen, Christian Dittrich, Peter Obrist, Norbert Marschner, L. Dirix, Marcus Schmidt, Dominik Rüttinger, Martin Schüler, Christoph Reinhardt,

Annals of Oncology · 2009 · 132 citations · 27 references

DOIFull text

Open access

Concepts

References

27